EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS187-11180 
Organism
Homo sapiens 
Tissue/cell
Th1 
Coordinate
chr17:80549090-80552120 
TF binding sites/motifs
Number: 19             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
EWSR1-FLI1MA0149.1chr17:80551231-80551249GGAGGGAGGGAGGGAGGG+6.03
EWSR1-FLI1MA0149.1chr17:80551235-80551253GGAGGGAGGGAGGGAGGG+6.03
EWSR1-FLI1MA0149.1chr17:80551250-80551268GGGAAAGAGGAAGGAAGG+6.14
EWSR1-FLI1MA0149.1chr17:80551254-80551272AAGAGGAAGGAAGGAAAG+6.23
EWSR1-FLI1MA0149.1chr17:80551239-80551257GGAGGGAGGGAGGGAAAG+6.31
EWSR1-FLI1MA0149.1chr17:80551258-80551276GGAAGGAAGGAAAGGAGA+6.82
EWSR1-FLI1MA0149.1chr17:80551227-80551245GGAAGGAGGGAGGGAGGG+7.12
EWSR1-FLI1MA0149.1chr17:80551223-80551241GGAAGGAAGGAGGGAGGG+7.97
EWSR1-FLI1MA0149.1chr17:80551219-80551237GGAAGGAAGGAAGGAGGG+9.72
KLF4MA0039.3chr17:80549241-80549252CCACACCCTGC+6.62
ZNF263MA0528.1chr17:80551255-80551276AGAGGAAGGAAGGAAAGGAGA+6.03
ZNF263MA0528.1chr17:80551256-80551277GAGGAAGGAAGGAAAGGAGAG+6.18
ZNF263MA0528.1chr17:80551244-80551265GAGGGAGGGAAAGAGGAAGGA+6.66
ZNF263MA0528.1chr17:80551220-80551241GAAGGAAGGAAGGAGGGAGGG+6.96
ZNF263MA0528.1chr17:80551236-80551257GAGGGAGGGAGGGAGGGAAAG+7.12
ZNF263MA0528.1chr17:80551224-80551245GAAGGAAGGAGGGAGGGAGGG+7.6
ZNF263MA0528.1chr17:80551240-80551261GAGGGAGGGAGGGAAAGAGGA+7.81
ZNF263MA0528.1chr17:80551232-80551253GAGGGAGGGAGGGAGGGAGGG+7.97
ZNF263MA0528.1chr17:80551228-80551249GAAGGAGGGAGGGAGGGAGGG+8.94
Number of super-enhancer constituents: 7             
IDCoordinateTissue/cell
SE_01005chr17:80548616-80552104Adrenal_Gland
SE_08753chr17:80547611-80552483Brain_Inferior_Temporal_Lobe
SE_23457chr17:80549045-80550903Colon_Crypt_1
SE_23457chr17:80551075-80552168Colon_Crypt_1
SE_24526chr17:80549996-80550760Colon_Crypt_2
SE_24526chr17:80551131-80552073Colon_Crypt_2
SE_31768chr17:80548538-80552181Gastric
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr178054944680549833
Enhancer Sequence
AGGTGACTCT GGGGTTGTCG CTCCAGCTGG AGTGTACCCT CATTCCTGCT TCCATAGGGG 60
TCTCCATGGA GGCCTCATTC AAACACAGGC GAGCCCATCC CTGGCCTGTC AGGTTCACCA 120
GGGTGGCCCC TGGTCCCGTT GTCGCCGTTG TCCACACCCT GCCCACCTGC CAATGCTCCT 180
GTGTCCCCTG CTCTGCTCCA GGGCCCCAAA CCCTGTGCAG AGCTGGGGTG CATCATGCTG 240
CCGCCCCATG GAGAAGGCCT GGAGGAGATG GAAGCCGGGA GGCTTCCTCT TACAGGAAGG 300
GAAGCCCCAG AAATGTGCCT GGCACCAAGA AACTGCTCCA AGCTTGTTCC AGAGTGTGGG 360
GAGGGCTTGA GGCCTCCCCT TTTTGAGTAC ATGGAAAGGA AAGCCTGGCA TTTTCTGGAA 420
ACGCTCCCAA GTCTCCCTGG CAGGGAGATG TGGGAAGAGT CCAGGCGCCC AAGCTCTTGC 480
ATATTCACTT CCTCCCATCA CACGTGCTGT GTACAAGCAC CCTCAGAGCT CGCTTTGGGA 540
GACCCCTGCC TCAGGGCTGC GGGTGCCGCC GTCCACACCA CAGGCCCTTC TGCTTCCTGT 600
TTCCAAAGCT CATCTCCTGT CTCTGGGCTG CAGGCGCTGT TTCTGGTTTA CTGGCACAAC 660
TGTGGTTGTG TTTTTGTCAA TGACTTCATC TTTGCTGCTG TTGTTTTGAG ATACTGTCTT 720
GCTCTGTCAC CCAGGCTGGA GTGCAGTGCC GAGATCTCAA CTCACTGCAG CCCCGACCTA 780
CTGGTCTCAA GCCATCCTCC TGCCTCAGCC TCCCAAGTAG CTGGGACTAC AGGTGTGCAG 840
CACCACATCC AGCTAAGTTT TTGTATTTTT TGTAGAGACA GGGTCTCACT ATGTTGCCCA 900
GGCTGGTTTC AAACTCCTGG ACTCTGGTGA TCCTCTAGCC TTGGCCTCCC AAAGTGCTGG 960
GATTACAGGT ACGAGCCAGC ATACCCAGCC AGTGTTGTCG TTTTGATTTG GGAGTTCGGG 1020
GCTGAGCTGT GTTTGGCCAG GGCCTCGCCT GCTCAGTGTG CTCCTGGGCT GAGCTGCGGT 1080
CCTGGAGCAT CTCTTGGCTC ACATATTGAC TCCTCCGGCC TCTCTACTGT CCTGGTCCTT 1140
CATGGGGCTC ACATGTGTGT CCTCTTGTTT TCTTTCTGTC ACCTTCTTAA GGGTTCACAG 1200
ATCACTGTCA GTGGAAGGTG TTGCCACAGC TCAAGCCTCA CAGTGGAGGA ACCTCATGAG 1260
GCCCTTCACG GGGCCACTCC CTGTCTGGAC AGGCCTGCCT GACCAGCCCT GCTGGGAAGC 1320
CTGGGCTTTG CTGCTGCTTC ACCCTGCGAC ATTCTCCTCA GGCCCTGCCT TTCGCTTCTT 1380
TCGTTAACAT TGTTCCTGCC TTGATCGTTT GCTCCCTCCT GCCTAACTCT GCTCTTCTTC 1440
CTTGTGTAGC AGTTACGTGG TCCTCAAATA TCATTTGTTG ACTCCAGTGT TTCCTGGGGC 1500
ATCTCCTCAA GCTGGCTGGG GTTCTCTGCA TCTCAGCTGT GGCGCCTGGT GTGAGGGCGC 1560
ACGCTTCGCA GTGAGAGTGA AATGCCCAGT TCGCGCTGGC AGAGGGAGAC CCTGTGAAGG 1620
TCTCCCTGTG CCAGGCACAG GCTCTTATTC TGAAAGCAGA CCCCGTGAAG GTCTCCCTGT 1680
GCCGGGCACA GGCTCTTATT CTGAAAGTAG ACCCTGTGAA GGTCTCCCTG CGCCGGGCAC 1740
AGGCTCTTAT TCTGAAAGCA GACCCAGTGA AGGTCTCCCT GTACCGGGCA GAGGCTCTTA 1800
TTCTGAAAGC AGACCCCGTG AAGGTCTTCC TGTACCGGGC ACAGGCTCTT ATTCTGAAAG 1860
ACCCAGTGAA GGTCTCCCTG CGCCGGGCAC AGGCTCTTAT TCTGAAAGCA GACCCCGTGA 1920
AGGTCTCCCT GCACCGGGCA CAGGCTCTTA TTCTGAAAGC AGACCCAGTG AAGGTCTCCC 1980
TGTGCCAGGC AGAGGCTCTT ATTCTGAAAG CAGACCCAGT GAAGGTCTCC CTGTGCCAGG 2040
CAGAGGCTCT TATTCTGAAA GCAGACCCTG TGAAGGTCTC CCTGTACCGG GCACAGGCTC 2100
TTATTCTGAA AGGGTACGCA GCAGTTTCTG GAAGGAAGGA AGGAGGGAGG GAGGGAGGGA 2160
GGGAAAGAGG AAGGAAGGAA AGGAGAGCGA TAGGCACAGA GGAAGGTAGA TGAAGCCCCG 2220
CGCCCCCCTG GCGGAGCCCA GCCCTGTTCA CCGCGTGCTG TGCGGGTGCC TGTGCCAGGA 2280
TCAGCTGGCT GGACGGCTAT AGCCCCACGC CTGCAGGCCA CATACCTGGG AGAGTGTGGG 2340
CCTTCCGAGC CTTCTGGCTC CCGGCCCCAC AGAGGAATTA CGGTCCCATG TCCCTCACAA 2400
GGACCCTTGC AGAGGGAGCA GTGCATCGGC ACAGAGCAGG ACACAGGGGA GCCGGGCTGA 2460
GGCTGCGGGT CCCTTGTGGC CGCCAGGTGC TCACGCGTGC CTCGGTGGGG ATCTGGCAGC 2520
CAGATTTGGG GTGAGGATTT GATGATGTGG GTATCCCTAG CTGGTCCCAC AGTGACGATG 2580
GGTGTTGCGT TGTGAGCATG TAAAACGGCA GTGACGTCTG AGGGTCCCTG GACGTCTTTC 2640
ACACCCAGCC TCAAAGCGGA GCCTTTCCAG GCAGAGCAGC AGCTGCCGCC ACTGGATTGA 2700
CAGCCCCAGA GCAGCGGGAT CAGGCCACGC GGACGAGGAG GTGCGAGGCC TCGGGTCGGG 2760
GCCTGTGTTC TGCGGGAGCC GCACCCATCA TCGCTGTGGC GGTGGCAGTG GAGCAGCTGC 2820
TCTCGTGTCT GAGCTGCTCC GGCGTCTCTG TCCACAGTAT AGGGTCTTCT GATGCTTCCT 2880
GGAGGTCTCG GAGGGGCTTG CTGCGTGTAG TACCCACACA GCCCACAACT GGGGTGTTGT 2940
CAAGTGTTAT GACGTAGGTT GCCTGTGGAG TAAAAGTTGG CCGCTAAGAA ATGCTCTAGA 3000
CAGGCCGGGC ACGGCGGCTC ACACCTGTCA 3030